Literature DB >> 15876919

Pertussis sources of infection and routes of transmission in the vaccination era.

Joop Schellekens1, Carl-Heinz Wirsing von König, Pierce Gardner.   

Abstract

Vaccination against pertussis has resulted in reduction of the infection pressure of Bordetella pertussis (partial herd immunity), but the circulation of B. pertussis has persisted as a consequence of waning of vaccine-induced and naturally acquired immunity. An increase in the reported incidence of B. pertussis infection in older children, adolescents and young adults has been noted, resulting in a perceived resurgence of the disease in these age groups. Regardless of whether this resurgence is real or not, older groups are increasingly recognized as playing an important role in transmitting B. pertussis infection to incompletely immunized infants, in whom pertussis disease continues to cause severe and fatal illness, albeit at much lower levels than in the prevaccine era. Several studies have suggested that mothers, in particular, are a significant source of infection for infants. Adolescents, grandparents and health care workers can also play a role. By contrast, most adolescents acquire the infection from schoolmates and friends, whereas for adults the main sources are children and work colleagues. Furthermore teachers, child care workers and health care workers could be at increased risk of being exposed to, and transmitting, B. pertussis infection. Current immunization strategies inadequately control the circulation of B. pertussis, in part because of suboptimal adherence to current pediatric immunization guidelines. In addition to efforts to improve pertussis immunization rates in children, the expansion of pertussis immunization to target specific groups should be considered. Besides reducing morbidity in the targeted groups, these strategies could decrease the residual burden of pertussis morbidity and mortality in infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876919     DOI: 10.1097/01.inf.0000160909.24879.e6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  26 in total

Review 1.  Bordetella pertussis transmission.

Authors:  Elizabeth A Trainor; Tracy L Nicholson; Tod J Merkel
Journal:  Pathog Dis       Date:  2015-09-14       Impact factor: 3.166

2.  Enhanced surveillance for adverse events following immunization: Two years of dTap catch-up among high school students in Yukon, Canada (2004, 2005).

Authors:  Samara T David; Mhsc Colleen Hemsley; Paula E Pasquali; Bryce Larke; Jane A Buxton; Lee Y Lior
Journal:  Can J Public Health       Date:  2006 Nov-Dec

3.  Recent findings on pertussis epidemiology in Turkey.

Authors:  D Dilli; I Bostanci; Y Dallar; T Buzgan; H Irmak; M A Torunoğlu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

Review 4.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Authors:  Julie C Blackwood; Derek A T Cummings; Hélène Broutin; Sopon Iamsirithaworn; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

6.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

7.  Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations.

Authors:  C Y Wong; N J Thomas; M Clarke; C Boros; J Tuckerman; H S Marshall
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

9.  Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.

Authors:  Mirjam Kretzschmar; Peter F M Teunis; Richard G Pebody
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

10.  The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists.

Authors:  Jason Behrmann
Journal:  Allergy Asthma Clin Immunol       Date:  2010-09-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.